Ferroptosis in Human Diseases: Fundamental Roles and Emerging Therapeutic Perspectives
Open Access
- 26 November 2025
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 14 (12) , 1411
Abstract
Ferroptosis is a novel iron-sensitive subtype of regulated cell death (RCD), persisting under extreme lipid peroxidation and iron/redox imbalances. Unlike apoptosis, necroptosis, and pyroptosis, ferroptosis is a signaling-driven process mediated through iron metabolism imbalance, polyunsaturated fatty acid (PUFA) exceeding oxidation, and defects in its protective systems like Xc-/GSH/GPx4. Specifically, this review establishes that iron-driven ferroptosis is a central underlying pathomechanistic factor in a broad range of human diseases. Significantly, whether its modulation is therapeutic, it is entirely conditional on the specific disease context. Thus, its induction can provide a promising antidote for destructive cancer cells when conjoined with immuno-therapies to boost anticancer immunity. Conversely, iron-mediated ferroptosis suppression is a key factor in countering destructive changes in a whole range of degenerative and acute injuries. Current therapeutic approaches include iron chelators, lipid oxidation inhibitors, GPx4 activators, natural and active compounds, and novel drug delivery systems. However, against all odds and despite its intense therapeutic promise, its translation into a practical medicinal strategy faces many difficulties. Thus, a therapeutic agent specifically focused on its modulation is still lacking. The availability of selective biologic markers is a concern. The challenges in the direct pathologic identification of ferroptosis in a complex in vivo systemic scenario remain. Current avenues for its future development are pathogen infections, the discovery of novel regulating factors, and novel approaches to personalized medicine centered on its organ-level in vivo signatures.Keywords
Funding Information
- European Commission (PNRR M4C2-Investimento 1.4-CN00000041)
This publication has 234 references indexed in Scilit:
- Ferroptosis: biology and role in liver diseaseJournal of Gastroenterology, 2025
- Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCCCancer Immunology, Immunotherapy, 2025
- Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axisJournal of Cancer Research and Clinical Oncology, 2024
- Renal Epithelial Mitochondria: Implications for Hypertensive Kidney DiseaseComprehensive Physiology, 2023
- Resveratrol inhibits ferroptosis via activating NRF2/GPX4 pathway in mice with spinal cord injuryMicroscopy Research and Technique, 2023
- IFNγ-mediated repression of system xc− drives vulnerability to induced ferroptosis in hepatocellular carcinoma cellsJournal of Leukocyte Biology, 2021
- Iron Chaperone Poly rC Binding Protein 1 Protects Mouse Liver From Lipid Peroxidation and SteatosisHepatology, 2020
- Role of ferroptosis in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2018
- The Human Nramp2 Gene: Characterization of the Gene Structure, Alternative Splicing, Promoter Region and PolymorphismsBlood Cells, Molecules, and Diseases, 1998
- Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseaseJournal of Neural Transmission, 1997